Development of a Subcutaneous Formulation for Trastuzumab - Nonclinical and Clinical Bridging Approach to the Approved Intravenous Dosing Regimen
Year: 2012
Type: article
Source: Arzneimittelforschung
Authors: B. Bittner, W. Richter, F. Hourcade-Potelleret, C. McIntyre, F. Herting, M. Zepeda, J. Schmidt
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2001161794
